TG Therapeutics, Inc. Gains 40.85%
Thu, Dec 10, 2020 at 05:30 PM
TG Therapeutics, Inc. (TGTX:NASDAQ) jumped higher at $41.72, a gain of 40.9%. On Wed 09 Dec 20, TGTX:NASDAQ touched a New 2-Week Intraday High of $31.65. The stock appeared on our News Catalysts scanner on Thu 10 Dec 20 at 04:41 PM in the 'MISCELLANEOUS' category. From Wed 25 Nov 20, the stock recorded 44.44% Up Days and 40.00% Green Days
The stock spiked on Tue 13 Oct 20 at $31.97 with a volume of 1M+, and its share price has been moving sideways in recent weeks.
About TG Therapeutics, Inc. (TGTX:NASDAQ)
TG Therapeutics Inc is a biopharmaceutical company. It is engaged in the acquisition, development & commercialization of novel treatments for B-cell malignancies and autoimmune diseases.
Top 10 Gainers:
- SELLAS Life Sciences Group, Inc. (SLS:NASDAQ), 176.37%
- Immutep Limited (IMMP:NASDAQ), 164.65%
- Veru Inc. (VERU:NASDAQ), 53.47%
- Sangamo Therapeutics, Inc. (SGMO:NASDAQ), 52.98%
- Neos Therapeutics, Inc. (NEOS:NASDAQ), 47.7%
- TG Therapeutics, Inc. (TGTX:NASDAQ), 40.85%
- Arlington Asset Investment Corp. (AI:NYSE), 40.56%
- Peabody Energy Corporation (BTU:NYSE), 37.84%
- ALXO (ALXO:NASDAQ), 37.35%
- Silver Spike Acquisition Corp. (SSPK:NASDAQ), 37.27%